kras mutation and glutathion glynac

kras mutation and glutathion glynac Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Oncogenic Kras Maintains Pancreatic Tumors

Name: kras mutation and glutathion glynac Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Oncogenic Kras Maintains Pancreatic Tumors
Brand: equiscorp.hu
SKU: 38712159765
Price: 28.79 USD
Availability: InStock
Rating: 4.839700000000001 (5 reviews)

Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link Treatment of KRAS Mutated Pancreatic Cancer: New Hope for the Patients?

SKU: 38712159765 · From equiscorp.hu

4.8

USD28.79 USD75.79

Pay in 4 interest-free payments of $7.20 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

2011 ASCO Annual Meeting Abstracts Part 1

Host-directed therapies for bacterial and viral infections

Finally, important engineering advances in photothermal therapy notably a dual-laser (808 nm and 1064 nm) excitation strategy show how optical parameter optimization can overcome depth and heating heterogeneity limitations